Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia

Blood

Volumn 91, Issue 11, 1998, Pages 3995-4019

  Faderl, Stefan ^a   Kantarjian, Hagop M ^a,b   Talpaz, Moshe ^a   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; CYTOGENETICS; GENE REARRANGEMENT; HUMAN; KARYOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0032101546     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.3995.411a43_3995_4019     Document Type: Review

References (274)

1. Young JL Jr, Ries LG, Silvergerg E, Horm JW, Miller RW: Cancer incidence, survival and mortality for children younger than age 15 years. Cancer 58:589, 1986
2. Mauer AM: Acute lymphocytic leukemia, in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology (ed 4). New York, NY, McGraw-Hill, 1990, p 994
3. Heim S, Mitelman F: Cytogenetic methods and terminology, in Heim S, Mitelman F (eds): Cancer Cytogenetics (ed 2). New York, NY, Wiley-Liss, 1995, p 20
4. Williams DL, Harris A, Williams KJ, Brosius MJ, Lemonds W: A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 13:239, 1984
5. Mitelman F: The Third International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 4:96, 1981
6. Third International Workshop on Chromosomes in Leukemia: Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res 43:868, 1983
7. Groupe Français de Cytogénétique Hématologique: Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique. Blood 87:3135, 1996
8. Fenaux P, Laï JL, Morel P, Nelken B, Taboureau O, Deminatti M, Bauters F: Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3. Hematol Oncol 7:307, 1989
9. Rieder H, Ludwig W-D, Gassmann W. Thiel E, Löffler H, Hoelzer D, Fonatsch C: Chromosomal abnormalities in adult acute lymphoblastic leukemia: Results of the German ALL/AUL study group. Recent Results Cancer Res 131:133, 1993
10. Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G: Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 96:601, 1997
11. Williams DL, Raimondi S, Rivera G, George S, Berard CW, Murphy SB: Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia. N Engl J Med 313:640, 1985 (letter)
12. Yunis JJ: Recurrent chromosomal defects are found in most patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 11:125, 1984
13. Secker-Walker LM, Lawler SD, Hardisty RM: Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. Br Med J 2:1529, 1978
14. Secker-Walker LM, Chessells JM, Stewart EL, Swansbury GJ, Richards S, Lawler SD: Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: A long-term follow-up. Br J Haematol 72:336, 1989
15. Pui C-H, Crist WM, Look T: Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76:1449, 1990
16. Rubin CM, Le Beau MM: Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 13:202, 1991
17. Crist WM, Pui C-H: Clinical implications and molecular genetic analyses of pediatric acute lymphoblastic leukemia. Stem Cells 11:81, 1993
18. Bloomfield CD, Secker-Walker LM, Goldman AI, Van Den Berghe H, de la Chapelle A, Ruutu T, Alimena G, Garson OM, Colomb HM, Rowley JD, Kaneko Y, Whang-Peng J, Prigogina E, Philip P, Sandberg AA, Lawler SD, Mitelman F: Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 40:171, 1989
19. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of acute leukemia. Br J Haematol 33:451, 1976
20. Williams DL, Raimondi SC, Pui C-H, Rivera GK: Evolving chromosome patterns and new cytogenetic concepts in childhood acute lymphoblastic leukemia, in Gale RP, Hoelzer D (eds): Acute Lymphoblastic Leukemia: UCLA Symposia on Molecular and Cellular Biology, New Series, vol 108, New York, NY, Wiley-Liss, 1990
21. Williams DL, Tsiatis A, Brodeur GM, Look AT, Melvin SL, Bowman WP, Kalwinsky DK, Rivera G, Dahl GV: Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 60:864, 1982
22. Heerema NA, Palmer CG, Baehner AL: Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. Cancer Genet Cytogenet 17:165, 1985
23. Groupe Français de Cytogénétique Hématologique: Collaborative study of karyotypes in childhood acute lymphoblastic leukemia. Leukemia 7:10, 1993
24. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237, 1993
25. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgström GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Secker-Walker LM, Tricot G, Van Den Berghe H, Van Orshoven A, Vuopio P, Whang-Peng J: Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415, 1986
26. Walters R, Kantarjian HM, Keating MJ, Estey EH, Trujillo J, Cork A, McCredie KB, Freireich EJ: The importance of cytogenetic studies in adult acute lymphocytic leukemia. Am J Med 89:579, 1990
27. Micallef-Eynaud PD, Eden OB, Grace E, Ellis PM: Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 10:25, 1993
28. Ankathil R, Geetha N, Remani P, Gangadharan VP, Rajasekharan PG, Krishnan NM: Clinical implications of cytogenetic classification in adult acute lymphoblastic leukaemia patients. J Cancer Res Clin Oncol 122:370, 1996
29. Heerema NA: Cytogenetic abnormalities and molecular markers of acute lymphoblastic leukemia, in Pochebly C, Civin CI (eds): Childhood Acute Lymphoblastic Leukemia - Part I. Hematol Oncol Clin North Am 4:795, 1990
30. Harris MB, Shuster JJ, Carroll A, Look AT, Borowitz MJ, Crist WM, Nitschke R, Pullen J, Steuber CP, Land VJ: Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study. Blood 79:3316, 1992
31. Campbell LJ, Michael PM, White JS, Matthews JP: Prognostic implications of karyotypes in 159 newly diagnosed adult patients with acute lymphoblastic leukaemia. Blood 86:678a, 1995 (abstr, suppl 1).
32. Walters R, Kantarjian HM, Keating M, Estey E, Beran M, Andersson B, Koller C, McCredie K, Freireich E: Response and prognosis related to pretreatment bone marrow cytogenetics in adult acute lymphocytic leukemia. Blood 70:212a, 1987 (abstr, suppl 1)
33. Sandberg AA: Acute lymphoblastic leukemia, in Sandberg AA (ed): The Chromosomes in Human Cancer and Leukemia (ed 2). New York, NY, Elsevier, 1990, p 313
34. Heim S, Mitelman F: Acute lymphoblastic leukemia, in Heim S, Mitelman F (eds): Cancer Cytogenetics (ed 2). New York, NY, Wiley-Liss, 1995, p 180
35. Oshimura M, Freeman AI, Sandberg AA: Chromosomes and causation of human cancers and leukemia. XXIII. Near-haploidy in acute leukemia. Cancer 40:1143, 1977
36. Third International Workshop on Chromosomes in Leukemia: Chromosomal abnormalities in acute lymphoblastic leukemia: Structural and numerical changes in 234 cases. Cancer Genet Cytogenet 4:101, 1981
37. Third International Workshop on Chromosomes in Leukemia: Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 4:111, 1981
38. United Kingdom Cancer Cytogenetics Group: Primary, single, autosomal trisomies associated with haematological disorders. Leuk Res 16:841, 1992
39. Pettenati MJ, Rao N, Wofford M, Shuster JJ, Pullen DJ, Ling MP, Steuber CP, Carroll AJ: Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 75:6, 1994
40. Secker-Walker LM: Prognostic and biologic importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet 49:1, 1990
41. Raimondi SC, Roberson PK, Pui C-H, Behm FG, Rivera GK: Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood 79:3245, 1992
42. Betts DR, Kingston JE, Dorey EL, Young BD, Webb D, Katz FE, Gibbons B: Monosomy 20: A nonrandom finding in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2:182, 1990
43. Heim S, Mitelman F: Numerical chromosome aberrations in human neoplasia. Cancer Genet Cytogenet 22:99, 1986
44. Garipidou V, Yamada T, Prentice HG, Secker-Walker LM: Trisomy 8 in acute lymphoblastic leukemia (ALL): A case report and update of the literature. Leukemia 4:717, 1990
45. Silengo M, Vassallo E, Barisone E, Miniero R, Madon E: Monosomy 20 in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 59:177, 1992
46. Raimondi SC, Pui C-H, Head D, Behm F, Privitera E, Roberson PK, Rivera GK, Williams DL: Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemia. Leukemia 6:171, 1992
47. Berger R: Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet 94:8, 1997
48. Mitelman F, Heim S: Quantitative acute leukemia cytogenetics. Genes Chromosomes Cancer 5:57, 1992
49. Schiffer CA, Lee ET, Tomiyasu T, Wiernik PH, Testa JR: Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphoblastic leukemia. Blood 73:263, 1989
50. Sandberg AA, Morgan R, Jani Sait S, Berger R, Flandrin G, Schrier S, Hecht F: Trisomy 4: An entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet 26:117, 1987
51. Kwong YL, Ha SY, Liu HW, Chan LC: Trisomy 4 may occur in a broad range of hematologic malignancies. Cancer Genet Cytogenet 69:139, 1993
52. Hodohara K, Fujiyama Y, Inoue T, Niwakawa M, Kitoh K, Andoh A, Bamba T, Hosoda S, Abe T: Trisomy 4 in a case of acute lymphocytic leukemia (L1). Cancer Genet Cytogenet 62:88, 1992
53. Zollino M, Leone G, Sica S, Bajer J, Neri G: Trisomy 4 in acute myeloblastic and acute lymphoblastic leukemia. Cancer Genet Cytogenet 65:115, 1993
54. Sandberg AA, Morgan SS, Morgan R, Boros L: Trisomy 5 as sole anomaly in acute lymphoblastic leukemia. Cancer Genet Cytogenet 36:31, 1988
55. Nagesh Rao P, Buss D, Brown S, O'Connor M, Hurd D, Pettenati J: Trisomy 5 as the sole abnormality in acute lymphoblastic leukemia. Cancer Genet Cytogenet 75:117, 1994
56. Chen Z, Morgan R, Sandberg AA: Non-random involvement of chromosome 5 in ALL. Cancer Genet Cytogenet 61:106, 1992 (letter)
57. Dabaja BS, Kantarjian H, O'Brien S, Estey E, Keating M: Deletion or losses in chromosomes 5 or 7 in adults with acute lymphocytic leukemia: Incidence, associations and implications. Blood 90:211b, 1997 (abstr, suppl 1)
58. Bonet C, Solé F, Woessner S, Florensa L, Besses C, SansSabrafen J: A case of monosomy 20 in an adult acute lymphoblastic leukemia. Cancer Genet Cytogenet 69:165, 1993 (letter)
59. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
60. Propp S, Lizzi FA: Philadelphia chromosome in acute lymphocytic leukemia. Blood 36:353, 1970
61. Melo JV: The diversity of bcr-abl fusion proteins and their relationship to leukemia phenotype. Blood 88:2375, 1996
62. Kurzrock R, Gutterman JU, Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319:990, 1988
63. Rowley JD: Chromosome abnormalities in human leukemia. Annu Rev Genet 14:17, 1980
64. Berger R, Chen SJ, Chen Z: Philadelphia-positive leukemia. Cytogenetic and molecular aspects. Cancer Genet Cytogenet 44:143, 1990
65. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
66. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, van Kessel AG, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkamp N, Stephenson JR, Groffen J: Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306:277, 1983
67. Soekarman D, van Denderen J, Hoefsloot L, Moret M, Meeuwsen T, van Baal, Hagemeijer A, Grosveld G: A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 4:397, 1990
68. de Klein A, Hagemeijer A, Bartram CR, Houwen R, Hoefsloot L, Carbonell F, Chen L, Barnett M, Greaves M, Kleihauer E, Heisterkamp N, Groffen J, Grosvels G: Bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood 68:1369, 1986
69. Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpaz M, Trujillo JM, Blick M, Beran M, Gutterman JU: A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukemia. Nature 325:631, 1987
70. Saglio G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A, Rege-Cambrin G, Mazza U, Gavosto F: New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 76:1819, 1990
71. Tuszynski A, Dhut S, Young BD, Lister TA, Rohatiner AZ, Amess JAL, Chaplin T, Dorey E, Gibbons B: Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia. Leukemia 7:1504, 1993
72. Saglio G, Guerrasio A, Rosso C, Lo Coco F, Frontani M, Annino L, Mandelli F: Detection of Ph'-positive acute lymphoblastic leukemia by PCR. Lancet 338:958, 1991
73. Westbrook CA, Hooberman L, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield C: Clinical significance of the bcr-abl fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762). Blood 80:2983, 1992
74. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:539, 1990
75. Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig W-D, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR: Detection of chimeric bcr-abl genes in acute lymphoblastic-leukemia by the polymerase chain reaction. Lancet 337:1055, 1991
76. Hooberman AL, Rubin CM, Barton KP, Westbrook CA: Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electrophoresis. Blood 74:1101, 1989
77. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R: Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 78:2411, 1991
78. Kurzrock R, Shtalrid M. Gutterman JU, Koller CA, Walters R, Trujillo JM, Talpaz M: Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemia. Br J Haematol 67:55, 1987
79. Secker-Walker LM, Craig JM: Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: A review. Leukemia 7:147, 1993
80. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV: Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, bcr breakpoint and prognostic significance. Leukemia 5:196, 1991
81. Gale RP, Butturini A: Ph-chromosome positive acute leukemias and acute phase CML: One or two diseases? Two. Leuk Res 14:295, 1990
82. Van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross N: p190 bcr-abl mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 87:5213, 1996
83. Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas ED, Appelbaum FR: Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after bone marrow transplantation. Blood 89:2602, 1997
84. Preti HA, O'Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM: Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients. Am J Med 97:60, 1994
85. 1- patients. Br J Haematol 36:347, 1977
86. Specchia G, Mininni A, Guerrasio A, Palumbo G, Pastore D, Liso V: Ph positive acute lymphoblastic leukemia in adults: Molecular and clinical studies. Leuk Lymphoma 18:37, 1995
87. Colleoni GWB, Yamamoto M, Kerbauy J, Serafim RC, Lindsey CJ, Costa FF, Grignolli CRE, Saad STO: Bcr-abl rearrangement in adult T-cell acute lymphoblastic leukemia. Am J Hematol 53:277, 1996 (letter)
88. Crist W, Carroll A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A, Hirt A, Brock B, Land V, Pullen J: Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group (POG) Study. Blood 76:489, 1990
89. Ribeiro RC, Abromowitch M, Raimondi SC, Murphy SB, Behm F, Williams DL: Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 70: 948, 1987
90. Copelan EA, McGuire EA: The biology and treatment of acute lymphoblastic leukemia in adults. Blood 5:1151, 1995
91. Radich J, Sanders J, Buckner CD, Martin PJ, Petersen FB, Hansen JA: Second allogeneic bone marrow transplants for patients relapsing after initial transplant with TBI-containing regimens. J Clin Oncol 11:304, 1993
92. Kowalczyk J, Sandberg AA: A possible subgroup of ALL with 9p-. Cancer Genet Cytogenet 9:383, 1983
93. Chilcote RR, Brown E, Rowley JD: Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med 313:286, 1985
94. Pollak C, Hagemeijer A: Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1:541, 1987
95. Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, LeBeau MM, Rowley JD: Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med 322:77, 1990
96. Laï JL, Fenaux P, Pollet JP, Estienne MH, Savary JB, Huart JJ, Deminatti M: Acute lymphocytic leukemia with 9p anomalies. Cancer Genet Cytogenet 33:99, 1988
97. Cayuela J-M, Madani A, Sanhes L, Stern M-H, Sigaux F: Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 87:2180, 1996
98. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, Kamb A: CDKN 2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061, 1995
99. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:2523, 1992
100. INK4 gene inactivation in the development of human acute lymphoblastic leukemia. Haematologica 80:557, 1995
101. Trent JM, Olson S, Lawn RM: Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci USA 79:7809, 1982
102. Carrera CJ, Eddy RL, Shows TB, Carson DA: Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization. Proc Natl Acad Sci USA 81:2665, 1984
103. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD: Homozygous deletion of the α- and β-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85:5259, 1988
104. Traweek ST, Riscoe MK, Ferro AJ, Braziel RM, Magenis RE, Fichten JH: Methylthioadenosine phosphorylase deficiency in acute leukemia: Pathologic, cytogenetic, and clinical features. Blood 71: 1568, 1988
105. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436, 1994
106. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753, 1994
107. DelSal G, Loda M, Pagano M: Cell cycle and cancer: Critical events at the G1 restriction point. Crit Rev Oncog 7:127, 1996
108. ink4a gene and hematological malignancies. Leuk Lymphoma 22:11, 1996
109. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 84:4038, 1994
110. INK4A) deletion in primary tumor cells of 163 leukemic patients. Blood 85:854, 1995 (letter)
111. INK4B gene deletions in primary leukemias. Blood 86:311, 1995
112. Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, Kamada N, Ohtake S, Uike N, Shimazaki C, Toyama K, Hirano M, Mizoguchi H, Kobayashi Y, Furusawa S, Saito M, Emi N, Yazaki Y, Ueda R, Hirai H: Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 86:1548, 1995
113. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Laï JL, Bauters F, Wattel E, Fenaux P: p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85:657, 1995
114. ink4 gene inactivation in acute lymphocytic leukemia. Blood 85:3431, 1995
115. Dreyling MH, Bohlander SK, Le Beau MM, Olopade OI: Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 86:1931, 1995
116. INK4B1. Cancer Res 56:722, 1996
117. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL: Frequent and selective methylation of p15 and deletion of p16 in T-cell acute lymphoblastic leukemia. Cancer Res 57:832, 1997
118. Schröder M, Mathieu U, Dreyling MH, Bohlander SK, Hagemeijer A, Beverloo BH, Olopade OI, Stilgenbauer S, Fischer K, Bentz M, Lichter P, Döhner H: CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia. Br J Haematol 91:865, 1995
119. Fizzotti M, Cimino G, Pisegna S, Alimena G, Quartarone C, Mandelli F, Pelicci PG, Lo Coco F: Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85:2685, 1995
120. Carroll AJ, Raimondi SC, Williams DL, Behm FG, Borowitz M, Castleberry RP, Harris MB, Patterson RB, Pullen DJ, Crist WM: tdic(9;12): A nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Blood 70:1962, 1987
121. United Kingdom Cancer Cytogenetics Group: Translocations involving 9p and/or 12p in acute lymphoblastic leukemia. Genes Chromosomes Cancer 5:255, 1992
122. Mahmoud H, Carroll AJ, Behm F, Raimondi SC, Schuster J, Borowitz M, Land V, Pullen DJ, Vietti TJ, Crist W: The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis. Leukemia 6:703, 1992
123. Behrendt H, Charrin C, Gibbons B, Harrison CJ, Hawkins JM, Heerema NA, Horschler-Bötel B, Huret J-L, Laï JL, Lampen F, Nelken B, Perot C, Ritterbach J, Schlegelberger B, Secker-Walker LM, Slater R, Slovak M, Tanzer J, Van Den Akker J: Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: Report from a dic(9;12) study group. Leukemia 9:102, 1995
124. Chen C-S, Sorenson PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH: Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81:2386, 1993
125. Janssen JWG, Ludwig W-D, Borkhardt A, Spadinger U, Rieder H, Fonatsch C, Hossfeld DK, Harbott J, Schulz AS, Repp R, Sykora K-W, Hoelzer D, Bartram CR: Pre-pre-B acute lymphoblastic leukemia: High frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood 84:3835, 1994
126. Kaneko Y, Skikano T, Maseki N, Sakurai M, Takeda T, Hiyoshi Y, Fujimoto T: Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 2:672, 1988
127. Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD: Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705, 1993
128. Ohshima A, Miura I, Chubaki A, Hashimoto K, Nimura T, Utsumi S, Takahashi N, Hayashi Y, Seto M, Ueda R, Miura AB: 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone. Am J Hematol 53:264, 1996
129. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735, 1991
130. Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA: A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet 2:113, 1992
131. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:701, 1992
132. Reeves R, Nissen MS: The AT-DNA-binding domain of mammalian high-morbidity-group I chromosomal proteins. J Biol Chem 265:8573, 1990
133. Rubnitz JE, Behm FG, Downing JR: 11q23 rearrangements in acute leukemia. Leukemia 10:74, 1996
134. Bernard OA, Berger R: Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 13:75, 1995
135. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau M, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909, 1993
136. Stock W, Thirman MJ, Dodge RK, Rowley JD, Diaz MO, Wurster-Hill D, Sobol RE, Davey FR, Larson RA, Westbrook CA, Bloomfield CD: Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B Study. Leukemia 8:1918, 1994
137. Griesinger F, Ludwig W-D, Falk M, Rieder H, Harbott J, Lampert F, Heinze B, Hoelzer D, Thiel E, Riehm H, Wörmann B, Fonatsch C, Hiddemann W: Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia 8:542, 1994
138. Zeleznik-Le NJ, Harden AM, Rowley JD: 11q23 translocations split the 'AT-hook' cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA 91:10610, 1994
139. Rogaia D, Grignani F, Carbone R, Riganelli D, Lo Coco F, NakamuraT, Croce CM, Di Fiore PP, Pelicci PG: The localization of the HRX/ALL1 protein to specific subnuclear domains is altered by fusion with its eps15 translocation partner. Cancer Res 57:799, 1997
140. Oshimura M, Freeman AI, Sandberg AA: Chromosomes and causation of human cancer and leukemia. XXVI. Banding studies in acute lymphoblastic leukemia (ALL). Cancer 40:1161, 1977
141. De Braekeleer M, Lin CC: 4;11 translocation-associated acute leukemia: A comprehensive analysis. Cancer Genet Cytogenet 21:53, 1986
142. Arthur DC, Bloomfield CD, Linquist LL, Nesbit MEJ: Translocation 4;11 in acute lymphoblastic leukemia: Clinical characteristics and prognostic significance. Blood 67:1, 1982
143. Fidanza V, Melotti P, Yano T, Nakamura T, Bradley A, Canaani E, Calabretta B, Croce CM: Double knockout of the ALL-1 gene blocks hematopoietic differentiation in vitro. Cancer Res 56:1179, 1996
144. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
145. Carroll AJ, Crist WM, Parmley RT, Roper M, Cooper MD, Finley WH: Pre-B cell leukemia associated with chromosome translocation 1;19. Blood 63:721, 1984
146. Pui C-H, Crist WM: Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlate with clinical features and treatment outcome. Leuk Lymphoma 7:259, 1992
147. Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui C-H, Crist WM, Look AT, Rivera GK: Cytogenetics of pre-B acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 8:1380, 1990
148. Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vietti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, Land VJ: Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13). A Pediatric Oncology Group Study. Blood 76:117, 1990
149. Pui C-H: Childhood leukemias. N Engl J Med 332:1618, 1995
150. Devaraj PE, Foroni L, Hoffbrand AV, Secker-Walker LM: Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia 9:821, 1995
151. Cortes JE, Kantarjian HM: Acute lymphoblastic leukemia. Cancer 76:2393, 1995
152. Shikano T, Kaneko Y, Takazawa M, Ueno N, Ohkawa M, Fujimoto T: Balanced and unbalanced 1;19 translocation-associated acute lymphoblastic leukemias. Cancer 58:2239, 1986
153. Pui C-H, Raimondi SC, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH, Sandlund JT, Crist WM, Behm FG: Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 12:2601, 1994
154. Rowley JD: Abnormalities of chromosome no.1: Significance in malignant transformation. Virchows Arch B Cell Path 29:139, 1978
155. Mamaeva SE, Mamaev NN, Jartseva NM, Belyaeva LV, Scherbakova EG: Complete or partial trisomy for the long arm of chromosome 1 in patients with various hematologic malignancies. Hum Genet 63:107, 1983
156. Mellentin JD, Murre C, Donlon TA, McCaw PS, Smith SD, Carroll AJ, McDonald ME, Baltimore D, Cleary ML: The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 246:379, 1989
157. Nichols J, Nimer D: Transcription factors, translocations, and leukemia. Blood 80:2953, 1992
158. Hunger S: Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: Clinical features and molecular pathogenesis. Blood 87:1211, 1996
159. Mellentin JD, Nourse J, Hunger SP, Smith SD, Cleary ML: Molecular analysis of the t(1;19) breakpoint cluster region in pre-B-ALL. Genes Chromosomes Cancer 2:239, 1990
160. Lu Q, Wright DD, Kamps MP: Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19). Mol Cell Biol 14:3938, 1994
161. LeBrun DP, Cleary ML: Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias. Oncogene 9:1641, 1994
162. Privitera E, Luciano A, Ronchetti D, Arico M, Santostasi T, Basso G, Biondi A: Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia. Leukemia 8:554, 1994
163. Izraeli S, Kovar H, Gadner H, Lion T: Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Blood 80:1413, 1992
164. Monica K, Galili N, Nourse J, Saltman D, Cleary ML: PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol Cell Biol 11:6149, 1991
165. Borowitz MJ, Hunger SP, Carroll AJ, Shuster JJ, Pullen DJ, Steuber CP, Cleary ML: Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: Implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: A Pediatric Oncology Group Study. Blood 82:1086, 1993
166. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT: Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257:531, 1992
167. Bernard O, Barin C, Charrin C, Mathieu-Mahul D, Berger R: Characterization of translocation t(1:14)(p32;q11) in a T and in a B acute leukemia. Leukemia 7:1509, 1993
168. Uckun FM, Gajl-Peczalska KJ, Provisor AJ, Heerema NA: Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood 73:271, 1989
169. Raimondi SC, Behm FG, Roberson PK, Pui C-H, Rivera GK, Murphy SB, Williams DL: Cytogenetics of childhood T-cell leukemia. Blood 72:1560, 1988
170. Human gene mapping 8. Helsinki conference: Eighth International Workshop on Human Gene Mapping. Cytogenet Cell Genet 40:1, 1985
171. Fenaux P, Laï JL, Miaux O, Zandecki M, Jouet JP, Bauters F: Burkitt cell acute leukemia (L3 ALL) in adults: A report of 18 cases. Br J Haematol 71:371, 1989
172. Baer R: TAL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukemia. Cancer Biol 4:341, 1993
173. Sánchez-García I, Rabbitts TH: LIM domain proteins in leukemia and development. Cancer Biol 4:349, 1993
174. Breit TM, Mol EJ, Wolvers-Tettero ILM, Ludwig W-D, van Wering ER, van Dongen JM: Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T-cell receptor α/β lineage: T cell receptor δ gene deletion mechanism affects multiple genes. J Exp Med 177:965, 1993
175. Aplan PD, Raimondi SC, Kirsch IR: Disruption of the SCL gene by a t(1;3) translocation in a patient with T-cell acute lymphoblastic leukemia. J Exp Med 176:1303, 1992
176. Janssen JWG, Ludwig W-D, Sterry W, Bartram CR: SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia 8:1204, 1993
177. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Graham Smith R, Baer R: Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group Study. Blood 86:666, 1995
178. Kwong YL, Chan D, Liang R: SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Cancer Genet Cytogenet 85:159, 1995
179. van Dongen JM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H: Detection of minimal residual disease in ALL: Recent Results Cancer Res 131:157, 1993
180. Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R: Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J 13:4831, 1994
181. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 373:432, 1995
182. Ono Y, Fukuhara N, Yoshie O: Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem 272:4576, 1997
183. Stock W, Westbrook CA, Sher D, Dodge R, Sobol RE, Wurster-Hill D, Davey FR, Larson RA, LeBeau MM, Aplan PD, Frankel SR, Stewart CC, Bloomfield CD: Low incidence of TAL1 gene rearrangement in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762). Clin Cancer Res 1:459, 1995
184. Bash RO, Crist WM, Shuster JJ, Link MP, Amylon M, Pullen J, Carroll AJ, Buchanan GR, Graham Smith R, Baer R: Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: A Pediatric Oncology Group Study. Blood 8:2110, 1993
185. Kikuchi A, Hayashi Y, Kobayashi S, Hanada R, Moriwaki K, Yamamoto K, Fujimoto J-I, Kaneko Y, Yamamori S: Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma. Leukemia 7:933, 1993
186. Dubé ID, Raimondi SC, Pi D, Kalousek DK: A new translocation t(10;14)(q24;q11 ) in T-cell neoplasia. Blood 67:1181, 1986
187. Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ: Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 253:79, 1991
188. Dubé ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G, Raimondi SC, Crist WM, Carroll AJ, Minowada J, Baker JB: A novel homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood 11:2996, 1991
189. Boehm T, Foroni L, Kennedy M, Rabbitts TH: The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerization motif. Oncogene 5:1103, 1990
190. Boehm T, Buluwela L, Williams D, White L, Rabbitts TH: A cluster of chromosome 11p13 translocations found via distinct D-D and D-D-J rearrangements of the human T cell receptor δ chain gene. EMBO J 7:2011, 1988
191. Erikson J, Finger L, Sun L, Ar-Rushdi A, Nishikura K, Minowada J, Finan J, Emanuel BS, Nowell PC, Croce CM: Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science 232:884, 1986
192. Mathieu-Mahul D, Sigaux F, Zhu C, Bernheim A, Mauchaffe M, Daniel M-T, Berger R, Larsen C-J: A t98;14)(q24;q11) translocation in a T-cell leukemia (L1-ALL) with c-myc and TCR-alpha chain locus rearrangements. Int J Cancer 38:835, 1986
193. Shima EA, LeBeau MM, McKeithan TW, Minowada J, Shove LC, Mak TW, Minden MD, Rowley JD, Diaz MO: Gene encoding the α-chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. Proc Natl Acad Sci USA 83:3439, 1986
194. Berger R, Bernheim J, Broquet JC, Daniel MT, Flandrin G: t(8;14) translocation in a Burkitt's type of lymphoblastic leukemia. Br J Haematol 43:87, 1979
195. Magrath IT, Ziegler JL: Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia. Leuk Res 4:33, 1979
196. Sullivan MP, Pullen DJ, Crist WM, Brecher M, Ramirez I, Sabio H, Borowitz MJ, Head DR, Cerezo L, Shuster JJ, Murphy SB: Clinical and biologic heterogeneity of childhood B cell acute lymphocytic leukemia: Implications for clinical trials. Leukemia 4:6, 1990
197. Gladstone B, Kadam PR, Balsara BR, Pai SK, Gopal R, Nair CN, Parikh PM, SaikiaT, Advani SH: Cytogenetic studies on patients of acute lymphoblastic leukemia Burkitt's type with (8;14) & (14;18) translocations. Indian J Med Res 99:264, 1994
198. Laï JL, Fenaux P, Zandecki M, Nelken B, Huart JJ, Deminatti M: Cytogenetic studies in 30 patients with Burkitt's lymphoma of L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities. Ann Genet 32:26, 1989
199. Croce CM, Nowell PC: Molecular basis of human B cell neoplasia. Blood 65:1, 1985
200. Korsmeyer SJ: Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10:785, 1992
201. Wiman KG, Clarkson B, Hayday AC, Saito H, Tonegawa S, Hayward WS: Activation of a translocated c-myc gene: Role of structural alterations in the upstream region. Proc Natl Acad Sci USA 81:6798, 1984
202. Joos S, Haluska FG, Falk MH, Henglein B, Hameister H, Croce CM, Bornkamm GW: Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc. Cancer Res 52:6547, 1992
203. Hollis GF, Mitchell KF, Battey J, Potter H, Taub R, Lenoir GM, Leder P: A variant translocation places the λ immunoglobulin genes 3′ to the c-myc oncogene in Burkitt's lymphoma. Nature 307:752, 1984
204. κ locus. Proc Natl Acad Sci USA 81:2444, 1984
205. Cesarman E, Dalla-Favera R, Bentley D, Groudine M: Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238:1272, 1987
206. Rabbitts TH, Hamlyn PH, Baer R: Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 306:760, 1983
207. Bhatia K, Huppi K, Spangler G: Point mutations in the c-myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genet 5:55, 1993
208. Thandla S, Aplan P: Molecular biology of acute lymphocytic leukemia. Semin Oncol 24:45, 1997
209. Prigogina EL, Fleischman EW, Puchkova GP, Kulagina OE, Majakova SA, Balakirev SA, Frenkel MA, Khvatova NV, Peterson IS: Chromosomes in acute leukemia. Hum Genet 53:5, 1979
210. Raimondi SC, Williams DL, Callihan T, Peiper S, Rivera GK, Murphy SB: Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 68:69, 1986
211. 27KIP1. Blood 86:3869, 1995
212. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley SD, Sallan SE, Gilliland DG, Golub TR: Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86:38, 1995
213. Aguiar RC, Sohal J, Van Rhee F, Carapeti M, Franklin IM, Goldstone AH, Goldman JM, Cross NC: TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. M.R.C. Adult Leukaemia Working Party. Br J Haematol 95:673, 1996
214. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Roberts JM, Trask BJ, LeBeau MM, Vogelstein B, Rowley JD, Bohlander SK: TEL and KIP1 define the smallest region of deletions in 12p13 in hematopoietic malignancies. Blood 86:1525, 1995
215. Golub TR, Barker GF, Lovett M, Gillilland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
216. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel A, Riegman P, Deprez R, Zwarhoff E, Hagemeijer A, Grosfeld G: Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511, 1995
217. Janssen JWG, Ridge SA, Papadopoulos P, Cotter F, Ludwig W-D, Fonatsch C, Rieder H, Ostertag W, Bartram CR, Wiedemann LM: The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. Br J Haematol 90:222, 1995
218. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
219. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosley MF, Martelli JJ, Cassiman JJ, Van den Berghe H: TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) or its variant t(10;12)(q24;p13). Blood 85:2848, 1995
220. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917, 1995
221. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA: The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662, 1995
222. Golub TR, Barker GF, Stegmaier K, Gilliland DG: The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. Curr Top Microbiol Immunol 220:67, 1997
223. Kim D-H, Moldwin RL, Vignon C, Bohlander SK, Suto Y, Giordano L, Gupta R, Fears S, Nucifora G, Rowley JD, Smith SD: TEL-AML1 translocations with Tel and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 88:785, 1996
224. Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP, Gilliland DG: Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res 56:1413, 1996
225. Wlodarska I, Baens M, Peeters P, Aerssens J, Mecucci C, Brock P, Marynen P, Van den Berghe: Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case. Cancer Res 56:2655, 1996
226. Golub TR, Barker GF, Stegmaier K, Gilliland DG: Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms, in Wolff L, Perkins AS (eds): Molecular Aspects of Myeloid Stem Cell Development. Curr Top Microbiol Immunol 211:279, 1996
227. Bernard OA, Romana SP, Poirel H, Berger R: Molecular cytogenetics of t(12;21)(p13;q22). Leuk Lymphoma 23:459, 1996
228. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B: The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891, 1996
229. Romana SP, Poirel H, Le Coniat M, Flexor M-A, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263, 1995
230. Fears S, Vignon C, Bohlander SK, Smith S, Rowley JD, Nucifora G: Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 17:127, 1996
231. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig W-D, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A for the "Associazione Italiana Ematologica Oncologia Pediatrica" and the "Berlin-Frankfurt-Münster" Study Group: Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 90:571, 1997
232. Romana SP, Le Coniat M, Berger R: t(12;21): A new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186, 1994
233. Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui C-H, Downing JR, Behm FG: Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A Pediatric Oncology Group Study. Blood 89:1143, 1997
234. Rubnitz JE, Downing JR, Pui C-H, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Bujis A, Grosveld G, Behm FG: TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance. J Clin Oncol 15:1150, 1997
235. Shurtleff SA, Bujis A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan G, Pui C-H, Grosveld G, Downing JR: TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup with an excellent prognosis. Leukemia 9:1985, 1995
236. McLean T, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JWG, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR: TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252, 1996
237. Lanza C, Volpe G, Basso G, Gottardi E, Barisone E, Spinelli M, Ricotti E, Cilli V, Perfetto F, Madon E, Saglio G: Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. Br J Haematol 97:460, 1997
238. Raynaud S, Mauvieux L, Cayuela JM, Bastard C, Bilhou-Nabera C, Debuire B, Bories D, Boucheix C, Charrin C, Fière D, Gabert J: TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 10:1529, 1996
239. Aguiar RC, Sohal J, Van Rhee F, Carapeti M, Franklin IM, Goldstone AH, Goldman JM, Cross NCP, on behalf of the M.R.C. Adult Leukemia Working Party LRF Centre for Adult Leukaemia: TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. Br J Haematol 95:673, 1996
240. Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ: Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukemia. Genes Chromosomes Cancer 10:26, 1994
241. Sherratt T, Morelli C, Boyle JM, Harrison CJ: Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chromosome Res 5:118, 1997
242. Gerard B, Cave H, Guidal C, Dastudue N, Vilmer E, Grandchamp B: Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia 11:28, 1997
243. Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ: Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia. Genes Chromosomes Cancer 10:286, 1994
244. Park JG, Reddy EP: Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6q- abnormalities of lymphoid tumors. Oncogene 7:1603, 1992
245. Menasce LP, White GR, Harrison CJ, Boyle JM: Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17:263, 1993
246. Garcia M, Derocq D, Freiss G, Rochefort H: Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 89:11538, 1992
247. Issa J-PJ, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH, Baylin SB: The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 56:973, 1996
248. de la Chapelle: How do human isochromosomes arise? Cancer Genet Cytogenet 5:173, 1982
249. Grasso M, Giovannucci Uziella ML, Pierluigi M, Tavellini F, Perroni L, Dagna Bricarelli F: Isochromosome not translocation in trisomy 21q21. Hum Genet 84:63, 1989
250. Martineau M, Clark R, Farrell DM, Hawkins JM, Moorman V, Secker-Walker LM: Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding. Genes Chromosomes Cancer 17:21, 1996
251. Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes Chromosomes Cancer 10:221, 1994
252. Pui C-H, Carroll AJ, Raimondi SC, Schell MJ, Head DR, Shuster JJ, Crist WM, Borowitz MJ, Link MP, Behm FG, Steuber CP, Land VJ: Isochromosomes in childhood acute lymphoblastic leukemia: A collaborative study of 83 cases. Blood 79:2384, 1992
253. Pui C-H, Raimondi SC, Williams DL: Isochromosome 17q in childhood acute lymphoblastic leukemia: An adverse cytogenetic feature in association with hyperdiploidy? Leukemia 2:222, 1988
254. Baker SJ, Markowits S, Fearon ER, Wilson JKV, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912, 1990
255. Nevins JR: E2F: A link between the Rb Tumor suppressor protein and viral oncoproteins. Science 258:424, 1992
256. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49, 1993
257. Levine AJ, Momand J: Tumor suppressor genes: The p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta 119:1032, 1990
258. Friend SH, Bernards R, Rogeij S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643, 1986
259. Ahuja HG, Jat PS, Foti A, Bar-Eli M, Cline MJ: Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 78:3259, 1991
260. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453, 1991
261. Ryan JJ, Danish R, Gottlieb CA, Clarke MF: Cell cycle analysis of p53-induced death in murine erythroleukemia cells. Mol Cell Biol 13:711, 1993
262. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345, 1991
263. Wada M, Bartram CR, Nakamura H, Hachiya M, Chen D-L, Borenstein J, Miller CW, Ludwig L, Hansen-Hagge TE, Ludwid W-D, Reiter A, Mizoguchi H, Koeffler HP: Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 82:3163, 1993
264. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Hirai H, Ishikawa F, Takaku F: Mutations of the p53 gene in lymphoid leukemia. Blood 77:1153, 1991
265. Fenaux P, Jonveaux P, Quiquandron I, Preudhomme C, Laï JL, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert P: Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: A report on 60 cases. Leukemia 6:42, 1992
266. Yeargin J, Cheng J, Haas M: Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia. Leukemia 6:85S, 1992 (suppl)
267. Lanza C, Gaidano G, Cimino G, Lo Coco F, Basso G, Sainati L, Pastore C, Nomdedeu J, Volpe G, Parvis G, Barisone E, Mazza U, Madon E, Saglio G: p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24. Leukemia 9:955, 1995
268. Kawamura M, Kikuchi A, Kobayashi S, Hanada R, Yamamoto K, Horibe K, Shikano T, Ueda K, Hayashi K, Sekiya T,Hayashi Y: Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia. Blood 85:2546, 1995
269. Diccianni MB, Yu J, Hsiao M, Mukherjee S, Shao LE, Yu AL: Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood 84:3105, 1994
270. Hsiao MH, Yu AL, Yeargin J, Haas M: Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase. Blood 83:2922, 1994
271. Preudhomme C, Dervite I, Wattel E, Vanrumbeke M, Flactif M, Laí JL, Hecquet B, Coppin MC, Nelken B, Gosselin B, Fenaux P: Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: A report of 48 cases. J Clin Oncol 13:812, 1995
272. Tsai T, Davalath S, Rankin C, Radich JP, Head D, Appelbaum FR, Boldt DH: Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in the Southwest Oncology Group studies. Leukemia 10:1901, 1996
273. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 87:4949, 1996
274. Rambaldi A, Attuati V, Bassan R, Neonato MG, Viero P, Battista R, Di Bona E, Rossi G, Pogliani E, Ruggeri M, Amaru R, Rivolta A, Giudici G, Biondi A, Barbui T: Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia. Lenk Lymphoma 21:457, 1996